News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
R3 Seminar Recap: Long COVID trajectories in adults
During the February 10, 2026, RECOVER Research Review (R3) Seminar, RECOVER researchers Sarah Donohue, PhD, MPH, and Tanayott (Tony) Thaweethai, PhD, presented research on Long COVID trajectories in adults. Published in November 2025, this research—which includes participants from the initiative’s adult observational cohort study—explores different clinical presentations of Long COVID and how the condition progresses over time. RECOVER Patient Representative and co-author Mady Hornig, MD, MA, and Timothy Henrich, MD, MMSc, a Long COVID researcher, also shared their perspectives and experiences.
R3 Seminar Recap
152 Results
152 Results
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
RECOVER-SLEEP enrollment process prioritized overall health of potential participants
While recruiting potential participants for its clinical trials focused on sleep disturbances, RECOVER study teams also conducted additional health screenings to identify and treat individuals with a sleep condition called sleep apnea.
Feature
Pregnancy and pediatric studies work together to learn how COVID affects mothers and their babies
Babies whose mothers had COVID while pregnant will help RECOVER researchers understand how the mother’s COVID case could impact childhood development.
Feature
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
Food insecurity and adverse social conditions tied to increased risk of Long COVID in children
In a study published in JAMA Pediatrics, RECOVER researchers analyzed data from over 4,500 school-aged children and adolescents to understand the relationship between social risk factors and the risk for developing Long COVID.
Announcement
RECOVER-TLC to hold next webinar January 23, 2026
On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
Announcement